Estudio de MK-6194 en participantes con colitis ulcerosa activa
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of MK-6194 in participants with active UC.
Merck Clinical Trials
Estudios Clínicos